Gene Modifiers of Cystic Fibrosis Lung Disease
Running, not enrolling
Conditions studied: Cystic Fibrosis, Lung Diseases
In brief
The purpose of this study is to examine genetic modifiers of the severity of cystic fibrosis lung disease.
Key facts
- Study ID
- NCT00037765
- Run by
- University of North Carolina, Chapel Hill
- People needed
- 600
- Starts
- 2001-09-01
- Expected to finish
- 2027-07-01
- Last updated by the study team
- 2025-09-23
Who can join
Age: any, up to 100. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosed with CF
You may not qualify if…
- Only those subjects who are not able to consent to this protocol
Where it is running
- Marsico Lung Institute — Chapel Hill, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.